Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload

Diuretics, including furosemide, metolazone, and spironolactone, have historically been the mainstay of therapy for acute decompensated heart failure patients. The addition of an aquaretic-like vasopressin antagonist may enhance diuresis further. However, clinical experience with this quadruple comb...

Full description

Saved in:
Bibliographic Details
Main Authors: Rita Jermyn, Naveed Rajper, Chelsea Estrada, Sagar Patel, Michelle Weisfelner Bloom, Nand K. Wadhwa
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2013/750794
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850167259017773056
author Rita Jermyn
Naveed Rajper
Chelsea Estrada
Sagar Patel
Michelle Weisfelner Bloom
Nand K. Wadhwa
author_facet Rita Jermyn
Naveed Rajper
Chelsea Estrada
Sagar Patel
Michelle Weisfelner Bloom
Nand K. Wadhwa
author_sort Rita Jermyn
collection DOAJ
description Diuretics, including furosemide, metolazone, and spironolactone, have historically been the mainstay of therapy for acute decompensated heart failure patients. The addition of an aquaretic-like vasopressin antagonist may enhance diuresis further. However, clinical experience with this quadruple combination is lacking in the acute setting. We present two hospitalized patients with acute decompensated heart failure due to massive fluid overload treated with a combination strategy of triple diuretics in conjunction with the aquaretic tolvaptan. The first patient lost 72.1 lbs. (32.7 kg) with an average urine output of 3.5 to 7.5 L/day over eight days on combined therapy with furosemide, metolazone, spironolactone, and tolvaptan. The second patient similarly achieved a weight loss of 28.2 lbs. (12.8 kg) over 4 days on the same treatment. Both patients maintained stable serum sodium, potassium, and creatinine over this period and remained out of the hospital for more than 30 days. Thus, patients hospitalized with acute decompensated heart failure due to volume overload can achieve euvolemia rapidly and without electrolytes disturbances using this regimen, while being under the close supervision of a team of cardiologists and nephrologists. Additionally, this therapy can potentially decrease the need for ultrafiltration and the length of hospital stay.
format Article
id doaj-art-e30938c10ab94ad4995fc4532633ca39
institution OA Journals
issn 2090-6404
2090-6412
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Cardiology
spelling doaj-art-e30938c10ab94ad4995fc4532633ca392025-08-20T02:21:14ZengWileyCase Reports in Cardiology2090-64042090-64122013-01-01201310.1155/2013/750794750794Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume OverloadRita Jermyn0Naveed Rajper1Chelsea Estrada2Sagar Patel3Michelle Weisfelner Bloom4Nand K. Wadhwa5Division of Cardiology, Department of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADepartment of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADivision of Nephrology, Department of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADivision of Nephrology, Department of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADivision of Cardiology, Department of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADivision of Nephrology, Department of Medicine, Stony Brook Medicine, Stony Brook, NY 11794, USADiuretics, including furosemide, metolazone, and spironolactone, have historically been the mainstay of therapy for acute decompensated heart failure patients. The addition of an aquaretic-like vasopressin antagonist may enhance diuresis further. However, clinical experience with this quadruple combination is lacking in the acute setting. We present two hospitalized patients with acute decompensated heart failure due to massive fluid overload treated with a combination strategy of triple diuretics in conjunction with the aquaretic tolvaptan. The first patient lost 72.1 lbs. (32.7 kg) with an average urine output of 3.5 to 7.5 L/day over eight days on combined therapy with furosemide, metolazone, spironolactone, and tolvaptan. The second patient similarly achieved a weight loss of 28.2 lbs. (12.8 kg) over 4 days on the same treatment. Both patients maintained stable serum sodium, potassium, and creatinine over this period and remained out of the hospital for more than 30 days. Thus, patients hospitalized with acute decompensated heart failure due to volume overload can achieve euvolemia rapidly and without electrolytes disturbances using this regimen, while being under the close supervision of a team of cardiologists and nephrologists. Additionally, this therapy can potentially decrease the need for ultrafiltration and the length of hospital stay.http://dx.doi.org/10.1155/2013/750794
spellingShingle Rita Jermyn
Naveed Rajper
Chelsea Estrada
Sagar Patel
Michelle Weisfelner Bloom
Nand K. Wadhwa
Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
Case Reports in Cardiology
title Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
title_full Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
title_fullStr Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
title_full_unstemmed Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
title_short Triple Diuretics and Aquaretic Strategy for Acute Decompensated Heart Failure due to Volume Overload
title_sort triple diuretics and aquaretic strategy for acute decompensated heart failure due to volume overload
url http://dx.doi.org/10.1155/2013/750794
work_keys_str_mv AT ritajermyn triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload
AT naveedrajper triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload
AT chelseaestrada triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload
AT sagarpatel triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload
AT michelleweisfelnerbloom triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload
AT nandkwadhwa triplediureticsandaquareticstrategyforacutedecompensatedheartfailureduetovolumeoverload